Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.21
-0.27 (-0.95%)
At close: Apr 10, 2026, 4:00 PM EDT
28.29
+0.08 (0.28%)
After-hours: Apr 10, 2026, 4:35 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $20.19 billion as of April 10, 2026. Its market cap has increased by 165.18% in one year.
Market Cap
20.19B
Enterprise Value
15.77B
1-Year Change
165.18%
Ranking
Category
Stock Price
$28.21
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $20.19B, an increase of 3,685.31%. That is a compound annual growth rate of 97.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 20.38B | 35.06% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 27.04B |
| BioNTech SE | 22.66B |
| Moderna | 19.87B |
| Revolution Medicines | 19.08B |
| Incyte | 18.65B |
| Genmab | 16.66B |
| Summit Therapeutics | 14.90B |
| BridgeBio Pharma | 13.94B |